Review of NICE Technology Appraisal Guidance No 82; on the use of tacrolimus and pimecrolimus for the treatment of atopic eczema

Following consultation, the majority of comments received have led to the decision to defer the review of the original guidance until January 2009. During that  time, the evidence base will be re-assessed to ascertain whether there is a need to review the guidance.

21 December 2007 

TA82 review: Table of consultee and commentator responses